| Gene symbol | CD7 | Synonyms | GP40, LEU-9, TP41, Tp40 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q25.3 | dbXrefs | |
| Description | CD7 molecule | ||||
| GTO ID | GTC2740 |
| Trial ID | NCT04984356 |
| Disease | T-Cell Acute Lymphoblastic Leukemia | Lymphoblastic Lymphoma |
| Altered gene | CD7 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | WU-CAR-T-007 |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | A Phase 1/2 Study of the Safety and Efficacy of Anti-CD7 Allogeneic CAR-T Cells (WU-CART-007) in Patients With Relapsed or Refractory T-ALL/LBL |
| Year | 2021 |
| Country | Australia |
| Company sponsor | Wugen, Inc. |
| Other ID(s) | WU-CART-007 1001 |
| Cohort 1 | |||||||||||
|
|||||||||||